Decoding and Modulating Affective Brain States
Rumination, Major Depressive Disorder, Anxiety
About this trial
This is an interventional basic science trial for Rumination focused on measuring TMS, rumination, depression, anxiety
Eligibility Criteria
Inclusion criteria:
- 18-65 years old
- Right-handed
- Patient Health Questionnaire (PHQ-9 score) = or > than 10
- Comprehension of instructions in the English language.
- Capacity to provide informed consent and follow study procedures.
- Availability for the duration of the study.
Exclusion Criteria:
- Diagnosis of bipolar disorder (as PI discretion), schizophrenia or other psychotic disorder
- Recent use of psychoactive medications or substances as determined by investigators
- History of neurological disorder or traumatic brain injury (other than mild)
- Unable to have an MRI scan, or current or prior medical condition that could interfere with the collection or interpretation of MRI data
- Unable to receive or tolerate TMS
- Implanted devices, such as an aneurysm clip or cardiac pacemaker
- History of stroke, epilepsy, or brain scarring
- Pregnant, nursing, or trying to become pregnant (self-attestation alone)
- Otherwise determined by investigator to be unfit for study
Sites / Locations
- University of PennsylvaniaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Neuromodulation using the optimal rTMS stimulation frequency
Neuromodulation using the least optimal rTMS stimulation frequency
Through manipulation of brain state with a negative-affect task and using fMRI as the feedback signal, we aim to fine-tune repetitive Transcranial Magnetic Stimulation (rTMS) delivery to maximally impact the desired brain states in awake behaving study participants in a highly individualized manner (Visit 3: TMS/fMRI). The optimal rTMS stimulation frequency will be tested in a 3-day rTMS neuromodulation intervention.
We will compare the results of the optimal rTMS frequency neuromodulation with a separate 3-day neuromodulation session using the least optimal rTMS frequency, as determined by Visit 3: TMS/fMRI.